These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 24801058

  • 1. Positron emission tomography in the evaluation of pulmonary nodules among patients living in a coccidioidal endemic region.
    Reyes N, Onadeko OO, Luraschi-Monjagatta Mdel C, Knox KS, Rennels MA, Walsh TK, Ampel NM.
    Lung; 2014 Aug; 192(4):589-93. PubMed ID: 24801058
    [Abstract] [Full Text] [Related]

  • 2. FDG PET/CT evaluation of pathologically proven pulmonary lesions in an area of high endemic granulomatous disease.
    Sebro R, Aparici CM, Hernandez-Pampaloni M.
    Ann Nucl Med; 2013 May; 27(4):400-5. PubMed ID: 23400394
    [Abstract] [Full Text] [Related]

  • 3. Solitary pulmonary nodule evaluation in regions endemic for infectious diseases: Do regional variations impact the effectiveness of fluorodeoxyglucose positron emission tomography/computed tomography.
    Purandare NC, Pramesh CS, Agarwal JP, Agrawal A, Shah S, Prabhash K, Karimundackal G, Jiwnani S, Tandon S, Rangarajan V.
    Indian J Cancer; 2017 May; 54(1):271-275. PubMed ID: 29199704
    [Abstract] [Full Text] [Related]

  • 4. Respiratory-gated imaging in metabolic evaluation of small solitary pulmonary nodules: 18F-FDG PET/CT and correlation with histology.
    Farid K, Poullias X, Alifano M, Regnard JF, Servois V, Caillat-Vigneron N, Petras S.
    Nucl Med Commun; 2015 Jul; 36(7):722-7. PubMed ID: 25793929
    [Abstract] [Full Text] [Related]

  • 5. Combination of positron emission tomography/computed tomography and chest thin-layer high-resolution computed tomography for evaluation of pulmonary nodules: Correlation with imaging features, maximum standardized uptake value, and pathology.
    Hou S, Lin X, Wang S, Shen Y, Meng Z, Jia Q, Tan J.
    Medicine (Baltimore); 2018 Aug; 97(31):e11640. PubMed ID: 30075545
    [Abstract] [Full Text] [Related]

  • 6. Dual-Time-Point FDG PET/CT to Distinguish Coccidioidal Pulmonary Nodules from Those Due to Malignancy.
    Pasha AK, Walsh TK, Ampel NM.
    Lung; 2015 Oct; 193(5):863-4. PubMed ID: 26202257
    [No Abstract] [Full Text] [Related]

  • 7. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
    Bryant AS, Cerfolio RJ.
    Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
    [Abstract] [Full Text] [Related]

  • 8. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT.
    Chun EJ, Lee HJ, Kang WJ, Kim KG, Goo JM, Park CM, Lee CH.
    Lung Cancer; 2009 Aug; 65(2):180-6. PubMed ID: 19155090
    [Abstract] [Full Text] [Related]

  • 9. ¹⁸F-fluoro-deoxy-glucose focal uptake in very small pulmonary nodules: fact or artifact? Case reports.
    Calcagni ML, Taralli S, Maggi F, Rufini V, Treglia G, Leccisotti L, Bonomo L, Giordano A.
    World J Surg Oncol; 2012 Apr 28; 10():71. PubMed ID: 22540935
    [Abstract] [Full Text] [Related]

  • 10. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
    Kim SC, Machac J, Krynyckyi BR, Knesaurek K, Krellenstein D, Schultz B, Gribetz A, DePalo L, Teirstein A, Kim CK.
    Ann Nucl Med; 2008 Apr 28; 22(3):165-70. PubMed ID: 18498030
    [Abstract] [Full Text] [Related]

  • 11. Characterization of solitary pulmonary nodules with 18F-FDG PET/CT relative activity distribution analysis.
    Zhao L, Tong L, Lin J, Tang K, Zheng S, Li W, Cheng D, Yin W, Zheng X.
    Eur Radiol; 2015 Jul 28; 25(7):1837-44. PubMed ID: 25636419
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.
    Dewan NA, Gupta NC, Redepenning LS, Phalen JJ, Frick MP.
    Chest; 1993 Oct 28; 104(4):997-1002. PubMed ID: 8404239
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic value of PET/CT in differentiating benign from malignant solitary pulmonary nodules.
    Dalli A, Selimoglu Sen H, Coskunsel M, Komek H, Abakay O, Sergi C, Cetin Tanrikulu A.
    J BUON; 2013 Oct 28; 18(4):935-41. PubMed ID: 24344020
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic accuracy of contrast-enhanced computed tomography and positron emission tomography with 18-FDG in identifying malignant solitary pulmonary nodules.
    Dabrowska M, Krenke R, Korczynski P, Maskey-Warzechowska M, Zukowska M, Kunikowska J, Orłowski T, Chazan R.
    Medicine (Baltimore); 2015 Apr 28; 94(15):e666. PubMed ID: 25881842
    [Abstract] [Full Text] [Related]

  • 15. Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules.
    Maiga AW, Deppen SA, Mercaldo SF, Blume JD, Montgomery C, Vaszar LT, Williamson C, Isbell JM, Rickman OB, Pinkerman R, Lambright ES, Nesbitt JC, Grogan EL.
    JAMA Surg; 2018 Apr 01; 153(4):329-334. PubMed ID: 29117314
    [Abstract] [Full Text] [Related]

  • 16. FDG uptake heterogeneity evaluated by fractal analysis improves the differential diagnosis of pulmonary nodules.
    Miwa K, Inubushi M, Wagatsuma K, Nagao M, Murata T, Koyama M, Koizumi M, Sasaki M.
    Eur J Radiol; 2014 Apr 01; 83(4):715-9. PubMed ID: 24418285
    [Abstract] [Full Text] [Related]

  • 17. Amide proton transfer-weighted imaging to differentiate malignant from benign pulmonary lesions: Comparison with diffusion-weighted imaging and FDG-PET/CT.
    Ohno Y, Kishida Y, Seki S, Yui M, Miyazaki M, Koyama H, Yoshikawa T.
    J Magn Reson Imaging; 2018 Apr 01; 47(4):1013-1021. PubMed ID: 28799280
    [Abstract] [Full Text] [Related]

  • 18. Characterization of pulmonary lesions with low F-18 FDG uptake using double phase F-18 FDG PET/CT: comparison of visual and quantitative analyses.
    Kim IJ, Kim SJ, Kim YS, Lee TH, Jeong YJ.
    Neoplasma; 2009 Apr 01; 56(1):33-9. PubMed ID: 19152243
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.